Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral B/F/TAF After Discontinuing Injectable CAB + RPV

NCT06104306 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT06104306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06104306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral B/F/TAF After Discontinuing Injectable CAB + RPV
Lead sponsor
Gilead Sciences
Phase
Phase 4
Overall status
Completed
Start date
December 13, 2023
Completion date
April 23, 2025
Enrollment
33 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection